G. Catimel

Multicenter, randomized comparative study of two doses of paclitaxel in patients with metastatic breast cancer.

J.-M. Nabholtz, Karen A. Gelmon, M. Bontenbal et al. · Journal of Clinical Oncology · 1996 · 382 citations

Docetaxel (Taxotere®): An active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck

G. Catimel, Jaap Verweij, Vera Mattijssen et al. · Annals of Oncology · 1994 · 258 citations

Active Drug, Medicine, Pharmacotherapy +7

Phase II trial of CPT-11 in patients with advanced pancreatic cancer, an EORTC early clinical trials group study

D.J.Th. Wagener, H.E.R. Verdonk, Luc Dirix et al. · Annals of Oncology · 1995 · 182 citations

Pancreatic Cancer, Phase Ii Trial, Gastrointestinal Oncology +9

Population pharmacokinetics and pharmacodynamics of irinotecan (CPT-11) and active metabolite SN-38 during phase I trials

G G Chabot, D Abigerges, G. Catimel et al. · Annals of Oncology · 1995 · 172 citations

Pharmacological Study, Medicine, Active Metabolite Sn-38 +5

Phase II study with Docetaxel (Taxotere®) in advanced soft tissue sarcomas of the adult

Q G van Hoesel, Jaap Verweij, G. Catimel et al. · Annals of Oncology · 1994 · 142 citations

Surgical Oncology, Malignant Disease, Medicine +6